Bethany Samuelson Bannow MD, MCR retweeted
Reluctance to discuss heavy menstrual bleeding — by patients & clinicians alike — can delay diagnosis of bleeding disorders and lead to other preventable complications 🩸
Read "Missed Signals" in @ASHClinicalNews ➡️ ow.ly/cnAI50Z80Xu
@bsamuelson_md
@ASH_hematology
Bethany Samuelson Bannow MD, MCR retweeted
What Classical Haematologists Need to Know About Female Reproductive Health – @TheLancetHaem
@bsamuelson_md
hemostasistoday.com/science/…
#HemostasisToday
Bethany Samuelson Bannow MD, MCR retweeted
Replying to @ASH_hematology
@ASH_hematology abstract deadline day!
🤞🏽Good luck to all submitting
🧑🏻🔬#Research is an essential part of our specialty
🩸#Hematology is an incredible field!
#MedTwitter @isth @umnmedschool @doctorpemm @acweyand @VincentRK @DevaSharma1981 @MaryCushmanMD @bsamuelson_md
Bethany Samuelson Bannow MD, MCR retweeted
It’s #ASHCRTI week in LaJolla.
@ASH_hematology
A week full of redoing study proposals, mentorship and forming life long professional friendships for participants and faculty - 28 trainees across classical and malignant hematology
#ASHTrainee
Bethany Samuelson Bannow MD, MCR retweeted
Join Dr. Bethany Samuelson Bannow (@bsamuelson_md) for a Virtual Event on Hemostasis and Cancer
hemostasistoday.com/insight/…
#Cancer #Event #Hematology #Hemostasis #HemostasisToday #InternationalExperts #OHSU #Thrombosis #Medicine #Health #MedEd #MedX
Bethany Samuelson Bannow MD, MCR retweeted
Global Voices in Hematology: ISTH Highlights Reach-the-World Fellow Dr. Gabrielle de Mello Santos
@isth
@bsamuelson_md
hemostasistoday.com/insight/…
#Hematology #HemostasisToday #ISTHPodcast #ReachTheWorld #Medicine #Health #MedEd #MedX
Bethany Samuelson Bannow MD, MCR retweeted
🎙️New ISTH Pulse Podcast episode! We teamed up with @Vasculearn for a powerful collab & you won't want to miss it! From complex cases to newly diagnosed patients, this episode is packed with clinical tips every healthcare professional can use.
🎧Tune in: bit.ly/3GgXl36
Bethany Samuelson Bannow MD, MCR retweeted
🐝 Heard the buzz about the ISTH Pulse Podcast at #ISTH2025? 🎧Our hosts Geoffrey Barnes and Bethany Samuelson Bannow are here to share why this podcast is making waves in the thrombosis and hemostasis world.
Watch the video now!
Bethany Samuelson Bannow MD, MCR retweeted
🎙️ New Episode Alert: “Clot, Clot, Who’s There?”
Anticoagulation therapy is life-saving—but also life-changing. In today’s episode, Dr. Bethany Samuelson Bannow @bsamuelson_md is joined by Dr. Erik Klok @Erik_Klok_MD and Dr. Geoff Barnes @GBarnesMD to talk about how we talk about anticoagulation. 🗣️💊
They’ll cover:
✅ Common patient concerns
✅ How to improve medication adherence
✅ Lifestyle conversations that matter
✅ Using shared decision-making to build trust
Whether you’re a clinician or someone supporting patients on this journey, this one’s a must-listen.
🎧 Brought to you by @isth International Society on Thrombosis and Haemostasis (ISTH) in partnership with Vasculearn Network and the editors of Thrombosis and Haemostasis at Thieme @ThiemeIntl
#VascularHealth #Anticoagulation #ClotClotWhosThere #Vasculearn #ISTH #SharedDecisionMaking #MedicalPodcast
vln.thrombosis.org/c/podcast…
Bethany Samuelson Bannow MD, MCR retweeted
Congratulations to Glaivy Batsuli, MD, for being a recipient of the Mid-Career Research Award! HTRS is proud to support Dr. Batsuli with research opportunities.
Bethany Samuelson Bannow MD, MCR retweeted
Who’s the new voice behind the mic? Join us as we introduce @bsamuelson_md as the newest co-host of the ISTH Pulse Podcast! She’s bringing bold ideas and a passion for reproductive health and equitable care.
🎙 Tune in to meet Bethany and hear her vision: bit.ly/4jIvSVC
Bethany Samuelson Bannow MD, MCR retweeted
🚨 New research finds women with BRCA1/2 mutations who received textured breast implants after mastectomy face a 16x higher risk of developing BIA-ALCL, a rare lymphoma. Study highlights need for awareness years after surgery.
🔗 ow.ly/ALWv50W94IZ
@BloodPortfolio
Bethany Samuelson Bannow MD, MCR retweeted
Dr. @AmandaKallen discusses the history of women’s health research and recent actions that are jeopardizing progress in women’s health. Listen to the full interview with NEJM Executive Managing Editor Stephen Morrissey (@srm128): nej.md/4mSedOh
Bethany Samuelson Bannow MD, MCR retweeted
The first issue of @BloodGlobalHema is out with great hematology research from all other the world. @BloodPortfolio @ASH_hematology @GACancerCenter
Bethany Samuelson Bannow MD, MCR retweeted
🎉About a year ago, we launched the ISTH Pulse Podcast with the incredible Geoff Barnes at the mic to bring you fresh insights, expert voices, and the latest in thrombosis & hemostasis.
We’re thrilled to announce that the ISTH Pulse Podcast is expanding! We’re adding a second host to amplify new voices and perspectives. Can you guess who’s joining the team?
Bethany Samuelson Bannow MD, MCR retweeted
🩸This #MenstrualHygieneDay let's advocate, educate, and empower! Join FWGBD in doing this by reading our #MHDay2025 newsletter here: conta.cc/3FuzNr6
Bethany Samuelson Bannow MD, MCR retweeted
💜To close out Women’s Health Week, we’re spotlighting a vital conversation for our clinician community:
How do we safely manage menstruation, anticoagulation, and contraception in patients with VTE?
Dr. Bethany Samuelson Bannow (@bsamuelson_md and @DrPeriodHackers ), a globally recognized expert in this space, breaks it all down in this episode of Clot Chronicles—from what to ask at the first visit to how to support long-term reproductive health.
📽️Watch now and share with your teams: youtu.be/9q7wpAdJ7GE
👉 Follow Bethany for more: @DrPeriodHackers
#WomensHealthWeek #ClotChronicles #Anticoagulation #MenstrualHealth #VTE #Contraception #Thrombosis #Hematology
Bethany Samuelson Bannow MD, MCR retweeted
Non-anemic iron deficiency (NAID) and iron deficiency anemia (IDA) affect millions of women, yet many are often underdiagnosed and undertreated. Why? Structural barriers, inconsistent diagnostic thresholds, and lack of awareness.
Learn more: ow.ly/SB8L50VtWOG
Bethany Samuelson Bannow MD, MCR retweeted
BREAKING from @NEJM
In cancer patients w/ Cancer-Associated Venous Thromboembolism, reduced-dose apixaban (2.5 mg BID) is :
🔘Noninferior to full-dose (5 mg BID) for VTE recurrence
🔘Lower bleeding risk (12.1% vs. 15.6%)
🔘Safer extended anticoagulation, same protection.
#Thrombosis #cancer @OncoAlert @Cihan_Ay_MD
DOI: 10.1056/NEJMoa2416112
Bethany Samuelson Bannow MD, MCR retweeted
When 14 journals choose to publish the same article simultaneously, you know the topic is important. This is about predatory journals, which are out to catch the inexperienced authors. If you are thinking of submitting a paper following an invitation, read this first. #publishing
































